Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Found 21816 matches for

Harry Orlans will work with Robert MacLaren to develop a treatment for retinitis pigmentosa.

Amblyopia VR

Neural mechanisms of visual plasticity in amblyopia

Important Notes

CODETECT Patient Notification Statement

Research sites

Use of personal data

Introduction of a new Researcher Pay Scale

NDCN members

Jody Ede

Postdoctoral clinical academic nurse researcher

George Milner

Academic Foundation Doctor

Rebecca Dalton

Research Physiotherapist

Marianne Beach

Academic Foundation Doctor

Alessandra Morelli

Research midwife

Charlotte Harrison

Academic Clinical Fellow

Stephen Gerry

Senior Medical Statistician

Elizabeth King

Physiotherapist and doctoral candidate

Owen Gustafson

Postdoctoral research physiotherapist

Verena Michael

Academic Foundation Doctor

HEROES Study

Mae Chester-Jones

NIHR Doctoral Research Fellow

Cristian Roman

Senior research associate in biomedical engineering

Load More

Similar stories

Wellcome Discovery Award granted to Professor Robert MacLaren

Professor Robert MacLaren has been awarded a prestigious Wellcome Discovery Award to advance the development of CRISPR strategies to treat inherited retinal diseases, which are a leading cause of childhood visual impairment in the UK and of blindness in people of working age.

Professor Russell Foster awarded Foreign Fellowship of INSA

Russell Foster featured in 100 Faces campaign

Brief sleep therapy delivered by nurses improves insomnia

New imaging method trialled for retinal diseases

Beacon Therapeutics launched to develop new generation of gene therapies for retinal diseases